These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa. Gawel M, Riopelle R, Libman I, Bouchard S. Adv Neurol; 1987; 45():535-8. PubMed ID: 3548263 [No Abstract] [Full Text] [Related]
4. Clinical inquiry. Which drugs work best for early Parkinson's disease? Jain L, Benko R, Safranek S. J Fam Pract; 2012 Feb; 61(2):106-8. PubMed ID: 22312616 [Abstract] [Full Text] [Related]
5. A comparison of bromocriptine (Parlodel) and levodopa-carbidopa (Sinemet) for treatment of "de novo" Parkinson's disease patients. Libman I, Gawel MJ, Riopelle RJ, Bouchard S. Can J Neurol Sci; 1987 Nov; 14(4):576-80. PubMed ID: 3319120 [Abstract] [Full Text] [Related]
6. Mood swings associated with the 'on-off' phenomenon in Parkinson's disease. Nissenbaum H, Quinn NP, Brown RG, Toone B, Gotham AM, Marsden CD. Psychol Med; 1987 Nov; 17(4):899-904. PubMed ID: 3432464 [Abstract] [Full Text] [Related]
7. A comparative study of bromocriptine and levodopa in Parkinson's disease. Duvoisin RC, Mendoza MM, Yahr MD. Adv Biochem Psychopharmacol; 1980 Nov; 23():271-5. PubMed ID: 7395618 [No Abstract] [Full Text] [Related]
8. Result of chronic levodopa therapy and its modification by bromocriptine in Parkinson's disease. Hoehn MM. Acta Neurol Scand; 1985 Feb; 71(2):97-106. PubMed ID: 3984685 [Abstract] [Full Text] [Related]
9. Low-dosage treatment in de novo patients with Parkinson's disease: a prospective study. van der Drift JH. Adv Neurol; 1987 Feb; 45():529-34. PubMed ID: 3825731 [Abstract] [Full Text] [Related]
10. Parallel double-blind study of pergolide in Parkinson's disease. Jankovic J, Orman J. Adv Neurol; 1987 Feb; 45():551-4. PubMed ID: 3548265 [No Abstract] [Full Text] [Related]
11. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect. Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340 [Abstract] [Full Text] [Related]
14. Drugs for parkinsonism. Med Lett Drugs Ther; 1986 Jun 20; 28(716):62-4. PubMed ID: 3713639 [No Abstract] [Full Text] [Related]
15. [Treatment of Parkinson's syndrome with a combination of levodopa and carbidopa]. Lombardo L, De la Garza R. Arch Invest Med (Mex); 1977 Jun 20; 8(2):123-8. PubMed ID: 907417 [Abstract] [Full Text] [Related]
17. [Treatment of Parkinson's disease with levodopa and a dopa decarboxylase inhibitor]. Londoõ R. Neurol Neurocir Psiquiatr; 1976 Jun 20; 17(4):293-300. PubMed ID: 1018729 [Abstract] [Full Text] [Related]
18. False positive diagnosis of phaeochromocytoma in a patient with Parkinson's disease receiving levodopa. Quinn N, Carruthers M. J Neurol Neurosurg Psychiatry; 1988 May 20; 51(5):728-9. PubMed ID: 3404174 [No Abstract] [Full Text] [Related]
20. Amantadine and a fixed combination of carbidopa and levodopa in parkinsonism: a preliminary report. Savery F. Curr Ther Res Clin Exp; 1976 Mar 20; 19(3):337-8. PubMed ID: 817863 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]